First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection-Reference-Cited by-同舟云学术

First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection

Published:2020-02-12 Issue:6 Volume:86 Page:1113-1124
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Chughlay M. Farouk¹^ORCID,Rossignol Emilie²,Donini Cristina¹,El Gaaloul Myriam¹,Lorch Ulrike³^ORCID,Coates Simon³,Langdon Grant⁴,Hammond Tim⁵,Möhrle Jörg¹,Chalon Stephan¹

Affiliation:

1. Medicines for Malaria Venture Geneva Switzerland

2. QIMR Berghofer Medical Research Institute Brisbane Australia

3. Richmond Pharmacology Ltd London UK

4. PTx Solutions UK

5. Preclinical Safety Consulting Ltd Loughborough Leicestershire UK

Funder

Janssen Pharmaceuticals

Medicines for Malaria Venture

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14219

Reference32 articles.

1. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission;Meremikwu MM;Cochrane Database Syst Rev,2012

2. New developments in anti-malarial target candidate and product profiles

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flexible 2,4-diaminopyrimidine bearing a butyrolactone as Plasmodium falciparum dihydrofolate reductase inhibitors;Bioorganic Chemistry;2024-12

2. Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development;Pharmaceuticals;2024-07-19

3. Novel flexible biphenyl PfDHFR inhibitors with improved antimalarial activity;RSC Medicinal Chemistry;2024

4. Flexible 2,4-Diaminopyrimidine Bearing a Butyrolactone as Plasmodium Falciparum Dihydrofolate Reductase Inhibitors;2024

5. Development of a Practical Synthetic Method for Clinical Candidate 3-(2-{3-[(2,4-Diamino-6-ethylpyrimidin-5-yl)oxy]propoxy} phenyl)propanoic acid (P218) and Its Hydroxylated Metabolites;Synthesis;2023-10-30